- Home
- CCEL vs VRCA Comparison
CCEL vs VRCA Comparison
Compare CCEL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- VRCA
- Stock Information
- Founded
- CCEL 1989
- VRCA 2013
- Country
- CCEL United States
- VRCA United States
- Employees
- CCEL N/A
- VRCA N/A
- Industry
- CCEL Managed Health Care
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- VRCA Health Care
- Exchange
- CCEL Nasdaq
- VRCA Nasdaq
- Market Cap
- CCEL 51.9M
- VRCA 58.0M
- IPO Year
- CCEL 1997
- VRCA 2018
- Fundamental
- Price
- CCEL $6.35
- VRCA $0.44
- Analyst Decision
- CCEL Strong Buy
- VRCA Hold
- Analyst Count
- CCEL 1
- VRCA 5
- Target Price
- CCEL $8.50
- VRCA $6.00
- AVG Volume (30 Days)
- CCEL 15.1K
- VRCA 543.9K
- Earning Date
- CCEL 04-14-2025
- VRCA 05-12-2025
- Dividend Yield
- CCEL 3.92%
- VRCA N/A
- EPS Growth
- CCEL N/A
- VRCA N/A
- EPS
- CCEL 0.05
- VRCA N/A
- Revenue
- CCEL $31,986,106.00
- VRCA $7,566,000.00
- Revenue This Year
- CCEL $2.21
- VRCA $118.94
- Revenue Next Year
- CCEL $0.98
- VRCA $94.35
- P/E Ratio
- CCEL $129.01
- VRCA N/A
- Revenue Growth
- CCEL 2.05
- VRCA 47.66
- 52 Week Low
- CCEL $5.75
- VRCA $0.39
- 52 Week High
- CCEL $9.50
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- CCEL 41.09
- VRCA 32.87
- Support Level
- CCEL $6.13
- VRCA $0.39
- Resistance Level
- CCEL $6.65
- VRCA $0.66
- Average True Range (ATR)
- CCEL 0.37
- VRCA 0.07
- MACD
- CCEL 0.04
- VRCA -0.01
- Stochastic Oscillator
- CCEL 42.86
- VRCA 17.82
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.